Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds SVB Leerink Maintains Outperform on Rocket Pharmaceuticals, Lowers Price Target to $64

SVB Leerink Maintains Outperform on Rocket Pharmaceuticals, Lowers Price Target to $64

SVB Leerink analyst Mani Foroohar maintains Rocket Pharmaceuticals (NASDAQ:RCKT) with a Outperform and lowers the price target from $66 to $64.

July 6, 2022

1 minute read

SVB Leerink analyst Mani Foroohar maintains Rocket Pharmaceuticals (NASDAQ:RCKT) with a Outperform and lowers the price target from $66 to $64.

What 9 Analyst Ratings Have To Say About Delta Air Lines

July 12, 12:43 PM

Analysts have provided the following ratings for Delta Air Lines (NYSE:DAL) within the last quarter:

November 11, 7:28 AM

Piper Sandler analyst Jason Bednar maintains Becton, Dickinson (NYSE:BDX) with a Neutral and lowers the price target from $255 to $245.

October 14, 2:11 PM

Analysts have provided the following ratings for Harmony Biosciences (NASDAQ:HRMY) within the last quarter:

May 31, 2:37 PM

Kohl's Corporation (NYSE: KSS) shares are trading lower by 2.58% to $18.51 Wednesday in reaction to recent calls for a boycott on social media.